Want to see AU:DRX full AI Analyst Report?
Top Page
Diatreme Resources Limited
(Sydney:DRX)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.01
▼(-35.00% Downside)
Action:Reiterated
Date:06/25/26
The score is weighed down primarily by weak operating fundamentals (unstable revenue, recurring operating losses, and persistent negative operating/free cash flow) despite a strong low-leverage balance sheet. Technicals are also bearish with price below all key moving averages and a negative MACD. Valuation is unattractive given the very high P/E and no dividend yield provided.
Positive Factors
Low-Leverage Balance Sheet
A very low debt-to-equity ratio provides durable financial flexibility: it reduces solvency risk, supports project development spending, and gives management optionality to raise capital on better terms or absorb setbacks over the next several months without immediate distress.
Negative Factors
Persistent Negative Cash Flow
Continual operating and free cash flow deficits signal ongoing cash burn and dependence on external funding. Over 2–6 months this constrains capital allocation, increases financing risk, and can force dilutive equity raises or expensive debt ahead of any meaningful operating improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Low-Leverage Balance Sheet
A very low debt-to-equity ratio provides durable financial flexibility: it reduces solvency risk, supports project development spending, and gives management optionality to raise capital on better terms or absorb setbacks over the next several months without immediate distress.
Read all positive factors
Diatreme Resources Limited (DRX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$60.10M
Dividend YieldN/A
Average Volume (3M)1.23M
Price to Earnings (P/E)120.0
Beta (1Y)0.73
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees5
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)<0.01
Shares Outstanding5,008,281,700
10 Day Avg. Volume2,234,875
30 Day Avg. Volume1,228,114
Financial Highlights & Ratios
PEG Ratio-0.95
Price to Book (P/B)1.03
Price to Sales (P/S)0.00
P/FCF Ratio-39.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Diatreme Resources Limited Business Overview & Revenue Model
Company Description
Diatreme Resources Limited is an Australian company dedicated to the exploration and identification of various mineral resources, including heavy mineral sands, copper, gold, and other base metals. Its primary undertaking is the Galalar Silica San...
How the Company Makes Money
null...
Diatreme Resources Limited Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
78
Positive
Cash Flow
24
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 886.46K | 468.51K | 110.14K | 23.94K |
| Gross Profit | -306.60K | 886.46K | 254.29K | -61.14K | -77.02K |
| EBITDA | -353.32K | -4.61M | 10.70M | -2.94M | -1.94M |
| Net Income | -744.96K | -439.53K | 10.37M | 4.98M | -2.15M |
Balance Sheet | |||||
| Total Assets | 94.51M | 95.45M | 66.53M | 55.33M | 33.14M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 5.19M | 10.77M | 13.64M | 6.50M |
| Total Debt | 1.05M | 1.20M | 1.75M | 1.54M | 1.61M |
| Total Liabilities | 2.23M | 2.51M | 2.96M | 2.59M | 2.37M |
| Stockholders Equity | 92.28M | 92.94M | 63.57M | 52.75M | 30.76M |
Cash Flow | |||||
| Free Cash Flow | -2.40M | -7.71M | -2.80M | -9.57M | -8.70M |
| Operating Cash Flow | -2.39M | -6.00M | -2.32M | -2.51M | -2.15M |
| Investing Cash Flow | -549.08K | 1.06M | -462.49K | -6.95M | -6.57M |
| Financing Cash Flow | 92.22K | -643.79K | -86.47K | 16.60M | 9.43M |
Diatreme Resources Limited Technical Analysis
Negative
0.02
Price Trends
0.01
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Negative
0.00
Negative
-50.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DRX, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 0.00 is Negative, neither overbought nor oversold. The STOCH value of -50.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DRX.
Diatreme Resources Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
53 Neutral | AU$67.87M | -14.75 | -4.91% | ― | ― | 25.21% | |
43 Neutral | AU$60.10M | 120.00 | -0.41% | ― | ― | ― | |
43 Neutral | AU$66.37M | 8.78 | 9.11% | ― | ― | ― | |
43 Neutral | AU$69.95M | -3.50 | -16.67% | ― | ― | 42.00% | |
42 Neutral | AU$69.14M | -0.88 | -67.75% | ― | ― | 69.69% | |
41 Neutral | AU$76.60M | -10.86 | -9.03% | ― | -78.48% | 52.16% |
* Basic Materials Sector Average
AU:DRX
Diatreme Resources Limited
0.01
>-0.01
-42.11%
AU:AGY
Argosy Minerals
0.04
0.02
61.54%
AU:BSX
Blackstone Minerals Ltd
0.04
-0.03
-45.33%
AU:E25
Element 25 Limited
0.24
0.00
0.00%
AU:HAS
Hastings Technology Metals Limited
0.31
0.01
4.10%
AU:NNL
Nordic Nickel Limited
0.18
0.10
125.00%
Diatreme Resources Limited Corporate Events
Diatreme Gains $4.4m Funding Boost as Sibelco Lifts Stake in Silica JV
Jul 7, 2026
Diatreme Resources has received a further $4.4 million in funding after joint venture partner Sibelco Silica exercised a call option to subscribe for additional shares in their Cape Silica Holdings vehicle. The move lifts total recent funding for ...
Diatreme Director Brian Flannery Lifts Indirect Stake via On-Market Purchase
Jun 29, 2026
Diatreme Resources Limited has disclosed a change in the holdings of director Brian Joseph Flannery, whose interest is held indirectly through Citicorp Nominees Pty Ltd on behalf of Ilwella Pty Ltd. This structure reflects his role as a director, ...
Diatreme boosts silica resource with maiden Casuarina estimate
Jun 22, 2026
Diatreme Resources has reported a maiden Mineral Resource Estimate of 102.7 million tonnes for its Casuarina Resource Area in Far North Queensland, contiguous with the existing Cape Flattery Silica Mine. The high-purity deposit, averaging about 99...
Diatreme installs Brian Flannery as chair to steer advancing silica sands projects
Jun 16, 2026
Diatreme Resources Limited, an emerging Australian producer and explorer of mineral and silica sands, focuses on high-purity, low-iron silica products from projects in Far North Queensland and zircon from Western Australia’s Eucla Basin. The...
Diatreme Finalises Cape Flattery Silica Sale to Sibelco Joint Venture
Jun 9, 2026
Diatreme Resources has completed the sale of its Cape Flattery Silica Project vehicle, Cape Flattery Silica Pty Ltd, to Cape Silica Holdings Pty Ltd, the joint venture company it shares with Sibelco. Under the deal, Metallica Minerals sold 100% of...
Diatreme extends $1m debt facility to fund flagship silica projects
Jun 2, 2026
Diatreme Resources has secured a 12-month extension of its existing A$1.0 million unsecured debt facility, pushing the maturity date to 30 May 2027 on unchanged terms, including a 7.5% annual interest rate. The refinancing extends a facility origi...
Diatreme Clears All AGM Resolutions, Greenlights Cape Flattery Silica JV Deal
May 29, 2026
Diatreme Resources Limited reported that all seven resolutions put to shareholders at its 29 May 2026 annual general meeting were passed by poll. The strong support included approval of the remuneration report, the re‑election of director Ch...
Diatreme pushes Northern Silica Project toward production amid surging solar demand
May 29, 2026
Diatreme Resources reported progress on its Northern Silica Project in North Queensland, lodging a draft environmental impact statement and expanding its silica sand resources to more than 530 million tonnes of high-purity, low-iron material. The ...
Diatreme Resources Simplifies Capital Structure as 30 Million Options Expire
May 27, 2026
Diatreme Resources Limited has reported the expiry of three series of listed options on 27 May 2026, covering a total of 29,999,, , shares equivalent in options that lapsed without being exercised. The cessation of these options, with exercise pri...
Diatreme lodges updated corporate governance statement and Appendix 4G
Apr 29, 2026
Diatreme Resources Limited has lodged its updated corporate governance statement for the financial year ending 31 December 2025, confirming that the document is current as of 29 April 2026 and approved by the board. The company has also filed the ...
Diatreme Resources Details Board and Leadership Structure in Annual Report
Apr 29, 2026
Diatreme Resources Limited has released its annual report, highlighting its current corporate governance structure and key board appointments. The report lists former Australian Treasurer Wayne Swan as non-executive chair, supported by a board inc...
Diatreme Sets 2026 AGM as Expert Backs Fairness of Proposed Transaction
Apr 29, 2026
Diatreme Resources has called its annual general meeting for 29 May 2026 in Brisbane, where shareholders will receive the 2025 financial statements and vote on the non-binding remuneration report. The company has also commissioned an independent e...
Diatreme bolsters balance sheet as it advances Northern Silica flagship
Apr 26, 2026
Diatreme Resources reported its full-year statutory accounts for 2025, highlighting progress across its portfolio of critical mineral projects, with a strong emphasis on advancing the Northern Silica Project. The company also continued to develop ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.